一批账号造谣“进口药退出中国”“集采器械质量差”！被处置

Core Viewpoint - The central government is actively addressing the spread of false information related to centralized drug procurement, which is crucial for public health and safety [1][2]. Group 1: Regulatory Actions - The Central Cyberspace Administration of China, in collaboration with the National Medical Insurance Administration, has taken measures to rectify online misinformation regarding centralized drug procurement [1]. - Several accounts have been identified and penalized for spreading false information that undermines the credibility of centralized procurement policies [2]. Group 2: Misinformation Tactics - Certain accounts have been found to fabricate negative information about the quality of drugs and medical supplies associated with centralized procurement to attract attention [1][2]. - Some accounts are misleading the public by associating non-procurement products with centralized procurement, thereby damaging the trust in the procurement system [2]. Group 3: Public Awareness - The authorities emphasize the importance of rational and scientific perspectives on drug procurement and urge the public to avoid spreading rumors [2].